Comparative effectiveness of different treatment pathways for opioid use disorder.

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816

Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017

Scholl, L., Seth, P., Kariisa, M., Wilson, N. O., & Baldwin, G. T. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm675152e1 · Cited by 1,754

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study

Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32812-x · Cited by 700

Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014

Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B. A., Iqbal, K., Ward, J. W., & Holtzman, D. J. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304132 · Cited by 699

The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis

Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677

National and state treatment need and capacity for opioid agonist medication-assisted treatment

Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302664 · Cited by 668

Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial

Weiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540

Medications for Opioid Use Disorder Save Lives

Mancher, M., & Leshner, A. (2019) · National Academies Press eBooks · doi:10.17226/25310 · Cited by 473

Advancing Opioid Use Disorder Treatment: A Narrative Review of Evidence-Based Solutions to Systems-Level Barriers in the US

Bailey, A., Kang, A. W. C., & Martin, R. A. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342261452648 · Cited by 1

National- and state-level burdens of substance use disorders in the USA, 1990–2023, with forecasts up to 2050: Global Burden of Disease Study 2023

Kang, J., Kim, H. J., Kim, M. S., Abedi, A., Abramov, D., Achore, M., Adegbile, O. E., Adzrago, D., Ahmed, A., Aly, H. Z., et al. (2026) · Med · doi:10.1016/j.medj.2026.101139 · Cited by 1

“Methadone at the pharmacy like Suboxone®?… It would untangle a lot of tangles.” Perspectives of North Carolinians with lived experience of opioid use on potential benefits of methadone dispensing at community pharmacies

Ostrach, B. M. M., Shubel, C., Carpenter, D. M., & Marley, G. T. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2670621 · Cited by 1

Adiposity and inflammation mediate altered metabolic profile in individuals with opioid use disorder

Li, X., Manza, P., Wang, G., Giddens, N. T., Belcher, A. M., Schwandt, M. L., Diazgranados, N., Lynch, K. G., Volkow, N. D., Shi, Z., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.06.021 · Cited by 1

Barriers and facilitators to pharmacy-based methadone dosing and dispensing: Semi-structured interviews with pharmacists

Marley, G. T., Nunnery, M. A., Shubel, C., Carpenter, D. M., & Ostrach, B. M. M. (2026) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2026.103472 · Cited by 1

Adverse events reported to FDA Adverse Event Reporting System for long-acting injectable buprenorphine during the first 18 months postlaunch

Dawson, B. J., Frost, M. P., Budilovsky-Kelley, N. R., Fiore, G. J., Friedman, A., Kaempfer, C., & Cohen, J. M. (2026) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2026.210095 · Cited by 1

Validation of Medicaid claim-based opioid treatment program retention quality measures

Burke, K., Mark, T. L., Dowd, W. N., Barch, D. H., Montgomery, B. W., Katz, C. L., DeLisle, D. E., & Zarkin, G. A. (2026) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2026.210109 · Cited by 1

Mortality in an Opioid Treatment Program

Bhatraju, E. P., Fuller, C. C., Grekin, P., Rockman, S., & Peavy, K. M. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2021.1909189 · Cited by 1

Substance Use: A Social Emergency Medicine Perspective

Samuels, E. A., Xuan, Z., & Bernstein, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-65672-0_10 · Cited by 1

Role of the pharmacist in acute care interventions for opioid use disorder: A scoping review

Irwin, M. N., & Walkerly, A. (2021) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1547 · Cited by 1

Reducing stigma toward medication for opioid use disorder through social work education, research, and practice

Pasman, E. (2021) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2021.1990643 · Cited by 1

Addictions

Butelman, E. R., Reed, B., Yuferov, V. P., & Kreek, M. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00025-3 · Cited by 1

Doing Our Best in a Broken System: The Urgent Need for Expansion of Medication for Opioid Use Disorder Treatments in the United States

Cohen, S. M., Tilley, J., Yocheved, A., & Sue, K. L. (2023) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001143 · Cited by 1

Medical treatments for opioid use disorder

McCord, E., Hale, C. V., & Tang, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98814-8.00018-4 · Cited by 1

Changes in daily dose in open-label compared to double-blind: The role of clients’ expectations in injectable opioid agonist treatment

Blawatt, S., Arreola, L. A. G., Magel, T., Macdonald, S., Harrison, S., Schechter, M. T., & Oviedo‐Joekes, E. (2023) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2023.100490 · Cited by 1

Changing approaches to treating opioid withdrawal in the USA

Hughes, M. E., Edinoff, A. N., & Sue, K. L. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00145-1 · Cited by 1

Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use

DeSisto, C. L., Terplan, M., Kacha-Ochana, A., Green, J. L., Mueller, T. E., Cox, S. N., & Ko, J. Y. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209083 · Cited by 1

Attitudes and beliefs about Vermont’s 2021 buprenorphine decriminalization law among residents who use illicit opioids

Feder, K. A., Harris, S. J., Byrne, L., Miller, S. M., Sodder, S., Berman, V., Livingston, A., Edwards, J. M., Hartman, S., Sugarman, O. K., et al. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110879 · Cited by 1

Differential risks of syringe service program participants in Central Ohio: a latent class analysis

Moon, K. J., Bryant, I., Trinh, A., Hasenstab, K. A., Carter, B., Barclay, R., & Nawaz, S. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00824-8 · Cited by 1

Extended-release injectable naltrexone for opioid use disorder

Ogbuchi, A. (2023) · Current Psychiatry · doi:10.12788/cp.0387 · Cited by 1

Public health approaches to address substance use: An urgent need of multisectoral engagement

Rabadan‐Diehl, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95356-6.00001-x · Cited by 1

The potential impact of clinical decision support on nonwaivered primary care clinicians’ prescribing of buprenorphine

Olson, A. W., Haapala, J. L., Hooker, S. A., Solberg, L. I., Borgert-Spaniol, C. M., Romagnoli, K. M., Allen, C. I., Tusing, L. D., Wright, E. A., Haller, I. V., et al. (2023) · Health Affairs Scholar · doi:10.1093/haschl/qxad051 · Cited by 1

Baseline Characteristics and Postdischarge Outcomes by Medication for Opioid Use Disorder Status Among Women with Polysubstance Use in Residential Treatment

Parlier‐Ahmad, A. B., Kelpin, S. S., Martin, C. E., & Svikis, D. S. (2023) · Women s Health Reports · doi:10.1089/whr.2023.0082 · Cited by 1

Guanfacine Treatment in a Patient with Intravenous Buprenorphine/Naloxone Misuse

Karabulut, S. (2024) · Case Reports in Psychiatry · doi:10.1155/2024/6359691 · Cited by 1

Frequent Use of Contingency Management and Opioid Treatment Programs that Provide Treatment for More than Only Opioid Use Disorder

Ware, O. D., Novak, M. D., & Toegel, F. (2024) · Journal of Drug Issues · doi:10.1177/00220426241238957 · Cited by 1

Effects of state opioid prescribing laws on rates of fatal crashes in the USA

White, S., McGinty, E. E., Origenes, A. N., & Vernick, J. S. (2024) · Injury Prevention · doi:10.1136/ip-2023-045159 · Cited by 1

Simulated impact of medicaid expansion on the economic burden of opioid use disorder in North Carolina

Barbosa, C., Dowd, W. N., Buell, N., Allaire, B. T., & Bobashev, G. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104449 · Cited by 1

Layperson knowledge on naloxone and medications for opioid use disorder in an urban population: a cross sectional survey study

Ramdin, C., Zembrzuska, M., Zembrzuski, K., & Nelson, L. S. (2024) · Journal of Addictive Diseases · doi:10.1080/10550887.2024.2353431 · Cited by 1

Error in Captions of Figures 1 and 2

(2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.19798 · Cited by 1

Simulating the effects of medicaid expansion on the opioid epidemic in North Carolina

Berghammer, A., Adams, J. W., Khan, S. S., & Bobashev, G. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100262 · Cited by 1

Emergency Department Buprenorphine and Naloxone Prescribing Disparities Among Racial and Ethnic Minorities Presenting With an Opioid Overdose

Davis, P., & Evans, D. D. (2024) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0000000000000519 · Cited by 1

A study of predictors of retention to naltrexone maintenance therapy in patients with opioid use disorder: a prospective study

Lone, B. B., Jan, N., Kousar, M. U., Bhat, F. R., Rather, Y. H., & Rasool, U. (2024) · Middle East Current Psychiatry · doi:10.1186/s43045-024-00450-5 · Cited by 1

Opioid Agonists and Perioperative Management of Patients on Maintenance Therapy

Boss, S., Bielawiec, T., Gwede, M., Ram, B. S., & Elmofty, D. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-67648-2_21 · Cited by 1

Psychometric performance of tools to measure internalized drug use stigma among people who use drugs and people on medication-assisted treatment in Dar es Salaam, Tanzania

Endres‐Dighe, S. M., Mlunde, L. B., Oga, E. A., Mbwambo, J. K. K., Shomari, Z., Mkufya, J., Nguma, E., Teemba, L. C., Saalim, K., & Nyblade, L. C. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112469 · Cited by 1

Illicitly Manufactured Fentanyl

Hooten, W. M. (2024) · Advances in Anesthesia · doi:10.1016/j.aan.2024.07.005 · Cited by 1

Use and perceptions of involuntary civil commitment among post‐overdose outreach staff in Massachusetts, United States: A mixed‐methods study

Cummins, E., Walley, A. Y., Xuan, Z., Yan, S., Schoenberger, S. F., Formica, S. W., Bagley, S. M., Beletsky, L. A., Green, T. C., Lambert, A. M., et al. (2024) · Addiction · doi:10.1111/add.16690 · Cited by 1

Medications for OUD: Extended-Release Naltrexone

Srivastava, A. B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00636-9 · Cited by 1

Evaluating the Efficiency and Productivity of Opioid Substitution Treatment Units in Greece: A DEA-Malmquist Analysis

Trakakis, A., Theocharis, A., & Prezerakos, P. E. (2025) · Healthcare · doi:10.3390/healthcare13080943 · Cited by 1

Pilot testing a novel remotely delivered intensive outpatient program for hospitalized patients with opioid use disorder

Szpak, V., Velez, A., Prostko, S., Rosenblum, N., Maurer, R., Aguiar, L. J., Weiss, R. D., & Suzuki, J. (2025) · Addiction Science & Clinical Practice · doi:10.1186/s13722-025-00589-4 · Cited by 1

Care for Opioid Use Disorder in Medical Settings: Lived Experiences

Siegel, Z., & Szalavitz, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1_15 · Cited by 1

Training Medical Students, Residents, and Fellows in Opioid Use Disorder Treatment

Morford, K. L., Falker, C. G., & Tetrault, J. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1_11 · Cited by 1

A Perspective from the Field: How Can We Empower the Next Generation of Physician to Heal the Opioid Epidemic?

Wylie, A., & Zacharoff, K. L. (2021) · Alcoholism Treatment Quarterly · doi:10.1080/07347324.2021.2002226 · Cited by 1

Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder

Frost, M. C., Richards, J. A., Blosnich, J. R., Hawkins, E. J., Tsui, J. I., Edelman, E. J., & Williams, E. C. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109521 · Cited by 1

Preserving dignity through expanded and sustained access to buprenorphine

Bratberg, J. P., & Falleni, A. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.12.026 · Cited by 1

Impact of Prerelease Methadone on Mortality Among People with HIV and Opioid Use Disorder After Prison Release: Results from a Randomized and Participant Choice Open-Label Trial in MalaysiaPreprint

Bazazi, A. R., Culbert, G. J., Wegman, M. P., Heimer, R., Kamarulzaman, A., & Altice, F. L. (2021) · Research Square · doi:10.21203/rs.3.rs-1054474/v1 · Cited by 1

The X Waiver to Prescribe Buprenorphine: The Why and How

Jones, K. F., Ho, J. J., Merlin, J. S., Weimer, M. B., Sager, Z. S., Kapo, J. M., & Childers, J. W. (2022) · Journal of Palliative Medicine · doi:10.1089/jpm.2022.0170 · Cited by 1

Adverse effects of opioids prescribed in opioid agonist treatment: a systematic review protocolPreprint

Meyer, M., Appenzeller‐Herzog, C., Cattaneo, M., & Hemkens, L. G. (2023) · doi:10.31219/osf.io/h2nr6 · Cited by 1

More data on opioid diversion is needed

Regenstreif, L. J., & Kahan, M. (2024) · Drug and Alcohol Review · doi:10.1111/dar.13840 · Cited by 1

How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain

Jones, K. F., Liou, K. T., Ashare, R. L., Worster, B. K., Yeager, K. A., Merlin, J. S., & Meghani, S. H. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.24.00705 · Cited by 1

Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative studyPreprint

Butelman, E. R., Huang, Y., McFarlane, A., Slattery, C., Goldstein, R. Z., Volkow, N. D., & Nelly Alia-klein, A. (2024) · medRxiv · doi:10.1101/2024.09.24.24314320 · Cited by 1

The ELEVATE Maternal Health Center of Excellence: A Program to Reduce Maternal Morbidity From Substance Use Disorder in Utah

Johnson, E. P., Smid, M. C., Cohen, S. R., Watt, M. H., Debbink, M. P., Gordon, A. J., Smith, J. D., Turok, D. K., Charles, J. E., Parker, E., et al. (2025) · Substance Use & Addiction Journal · doi:10.1177/29767342251336860 · Cited by 1

Commentary on Gibson et al. (2020): Medications for opioid use disorder– access, retention, and safety

Timko, C., & Hoggatt, K. J. (2020) · Addiction · doi:10.1111/add.15098

Incarceration and the Failure of Opioid Addiction Treatment in the United States

Light, S. C. (2020) · Contemporary Sociology A Journal of Reviews · doi:10.1177/0094306120963120b

Presence of Coronary Artery Disease in Patients on Methadone in the South Bronx: A Retrospective Analysis and Literature Review

Guerra, M. A. R., Urlapu, K. S., Hewapathirana, U., Vikram, I., Ked, F., Christian, M., Niel, M. D., & Timothy, V. (2021) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol06-i04/1111

Shifting the Paradigm: Patient-Centered Emergency Department Opioid Use Disorder Treatment

Schneberk, T. W. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.05.025

Emergency Department Treatment of Opioid Use Disorder

Samuels, E. A., Coupet, E., & D’Onofrio, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1_5

Principles of Integrating Opioid Use Disorder Treatment in Primary Care

Lu, T. Y., & Cunningham, C. O. (2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1_3

Cognitive Network Reconstruction in Opioid Users Compared To Non-Users: Topological Analysis of Cognitive Function Through Graph Model and Centrality MeasuresPreprint

Gharahi, E., Soraya, S., Ahmadkhaniha, H., Sadeghi, B., Haghshenas, M., & Bozorgmehr, A. (2021) · Research Square · doi:10.21203/rs.3.rs-1052526/v1

Uses and issues

Kumar, V. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90903-7.00011-9

References

Nelson, J. W., Felgen, J. A., & Hozak, M. A. (2021) · doi:10.1002/9781119747826.refs

Predicting Opioid Dependence Medication Effectiveness Using reviews from Health-Related social media: A case study on Methadone and Buprenorphine/Naloxone (Preprint)Preprint

Omranian, S., Zolnoori, M., Huang, M. S., & McRoy, S. (2022) · doi:10.2196/preprints.37207

Clouded Judgment

Madeira, J. L., Andraka‐Christou, B., Eldridge, L. A., & Silverman, R. D. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975452.013

Bibliography

Rossi, R. J. (2022) · Wiley eBooks · doi:10.1002/9781119722717.biblio

Acceptability of Mind-Body Therapy Among People with Opioid Use Disorder and Serious Bacterial InfectionsPreprint

Bearnot, B. I., Li, M. Y., Chukka, A., Lopes, M., Crute, S., Akpala, L., Park, E. R., Wakeman, S. E., Luberto, C. M., Rigotti, N. A., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4059834

Project BETTER: A technology-delivered intervention for pregnant people with opioid use disorder (Preprint)Preprint

Parlier‐Ahmad, A. B., Eglovitch, M., Martin, S., Svikis, D. S., & Martin, C. E. (2022) · doi:10.2196/preprints.40162

Attitudes Towards Medication for Opioid Use Disorders in Southern California: A Qualitative StudyPreprint

D'Ambrosio, B., Davidson, P. J., Bowles, J., Mittal, M. L., Clingan, S. E., Gaines, T. L., & Smith, L. R. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4116414

A Discussion of Critical Errors in the Study 'Longitudinal Study on Deterrent Effect of Drug-Induced Homicide Law on Opioid-Related Mortality Across 92 Counties and the District of Columbia in the U.S.'Preprint

Carroll, J. J., Bevis, L. E. M., El‐Sabawi, T., Figgatt, M. C., Dasgupta, N., Beletsky, L. A., Lieberman, A. J., Dennis, A., & Davis, C. S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4171058

Response to the Federation of State Physician Health Program's Commentary

Dwarakanath, M., & Klipp, S. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001088

Regional differences in buprenorphine distribution in Pennsylvania from 2010 to 2020

Mileto, A., Rinaldi, R. J., Grampp, S. J., McCall, K. L., & Piper, B. J. (2022) · Guthrie Journal · doi:10.53481/001c.57711

Substance use among methadone patients in Vietnam: a systematic review

Tran, T., & Rigg, K. K. (2023) · Journal of Substance Use · doi:10.1080/14659891.2022.2162989

Prescription

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-003

Notes

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-008

THE MEDICALIZATION AND CRIMINALIZATION OF PAIN

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-002

Quick Fixes to Enduring Problems

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-001

Bibliography

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-009

Methodological Note

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-007

When Medicine Becomes a Drug

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-006

Prison

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-005

Pipeline

(2023) · Duke University Press eBooks · doi:10.1215/9781478024330-004

A Descriptive Study on Opioid Misuse Prevalence and Office-Based Buprenorphine Access in Ohio Prior to the Removal of the Drug Addiction Treatment Act of 2000 Waiver

McKnight, E. R., Dong, Q., Brook, D., Hepler, S. A., Kline, D., & Bonny, A. E. (2023) · Cureus · doi:10.7759/cureus.36903

Contingency Management Treatment of Opioid Use Disorder

Holtyn, A. F., Toegel, F., & Novak, M. D. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.27

Spatio-Temporal Predictive Modeling for Placement of Substance Use Disorder Treatment Facilities in the Midwestern U.S

Pater, J. A., Guha, S., Pfafman, R., Kerrigan, C., & Toscos, T. (2023) · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering · doi:10.1007/978-3-031-34586-9_28

Risk of acute care incidents for people treated for opioid use disorder with extended-release naltrexone and buprenorphine

Hochheimer, M., Unick, G. J., & Sacco, P. (2023) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2023.2215093

Risk of opioid-related mortality associated with buprenorphine versus methadone: A systematic review of observational studiesPreprint

Lim, J., Farhat, I., Douros, A., Ouizzane, S., & Panagiotoglou, D. (2023) · medRxiv · doi:10.1101/2023.08.13.23294034

A Step Toward Equity: Evidence-Based Policy for Access to Medications for Healthcare Workers With Opioid Use Disorder

Salzman, M., Bryan, R. H., & Sharfstein, J. M. (2023) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(23)00109-6

Patient reported goals for medications for opioid use disorder: A theory of proximal goal attainment

Hohmeier, K. C., Cernasev, A., Leibold, C., Moore, T. M., Schlesinger, E., Arce, I., Geminn, W., Chisholm‐Burns, M. A., & Cochran, G. (2023) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2023.100345

Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder

Shulman, M., Greiner, M. G., & Bisaga, A. M. (2023) · Addiction · doi:10.1111/add.16374

How Does One Approach the Patient With an Opioid Use Disorder?

Ho, J. J., Jones, K. F., Merlin, J. S., & Childers, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-84702-5.00012-9

Chronic pain and opioid use disorder workshop for medical students: a biopsychosocial and multidisciplinary approach

Lai, B., Oesterle, T., Kelpin, S. S., Morrison, E. J. P., Elegbede, A. M., & Warner, N. S. (2023) · Pain Medicine · doi:10.1093/pm/pnad151

WestJEM Full-Text Issue

Valenzi, N. (2023) · Western Journal of Emergency Medicine · doi:10.5811/westjem.62602

Medication treatment of opioid use disorder in primary care practice: Opportunities and limitations

Barbieri, R. L. (2023) · OBG Management · doi:10.12788/obgm.0308

Sustainable Healthcare Provider OUD Assessment and Management in Rural Native American Communities (RNACs): Prevention, Treatment, and Recovery Approaches

Mincer, W. (2023) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc2179275

Efeitos do tratamento com Ibogaína em dependentes de opióides: uma revisão integrativa

Matta, F. L. D. S., Batista, V. F., Gimenes, A. D., Carlos, C. P., & Naoum, F. A. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n6-415

Standing in the Chasm: Therapeutic Action for Substance Use and Addicting

Bressi, S. K. (2024) · Psychoanalytic Social Work · doi:10.1080/15228878.2024.2310634

An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study

Wai, J. M., Blevins, D., Hunt, T., Gilbert, L., Campbell, A. N. C., LEVIN, F. R., El‐Bassel, N., & Nunes, E. V. (2024) · Psychiatric Services · doi:10.1176/appi.ps.20230159

Save a Life, Initiate Buprenorphine: Emergency Department Buprenorphine Administration

Kruse, M., & da Silva, J. (2024) · doi:10.1093/med/9780197635513.003.0013

Empowering Oncologists to Successfully Address Non-Medical Opioid Use During Cancer Treatment: A Review of Best Practices

Case, A. A. (2023) · Journal on oncology · doi:10.52768/2692-563x/1120

Perceptions of Community Corrections and Treatment Experience: A Qualitative Study Among People With Incarceration Histories Receiving Outpatient Methadone Treatment

Gazzola, M. G., Oberleitner, L., Hoffman, K. A., Eller, A., Madden, L. M., Marcus, R., Oberleitner, D. E., Beitel, M., Thompson, E., Zheng, X., et al. (2024) · Substance Use & Addiction Journal · doi:10.1177/29767342241238837

Improving Engagement in Residential Treatment for Sud: Integrated-Care Qi ProjectPreprint

Ramey, F. R., Stevenson, E., Derouin, A. L., Sharma, S., & Ruhiu, M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4780710

Serum cytokine and inflammatory markers in individuals with heroin use disorder: potential biomarkers for diagnosis and disease severityPreprint

Butelman, E. R., Huang, Y., Cathomas, F., Gaudreault, P., Roussos, P., Russo, S. J., Goldstein, R. Z., & Nelly Alia-klein, A. (2024) · medRxiv · doi:10.1101/2024.04.29.24306559

Treatment Pathways for Opioid Use Disorder in Commercially-Insured United States Adults from 2010-2019

Saini, J., Qato, D. M., Rizk, J. G., DiPaula, B. A., Ehret, M. J., Pathan, U., & Johnson, A. M. (2026) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.25-00480

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting

Morgan, J. R., Barocas, J. A., Murphy, S. M., Epstein, R. L., Stein, M. D., Schackman, B. R., Walley, A. Y., & Linas, B. P. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.29676 · Cited by 40

Comparative study shows superiority of medications for opioid use disorder

(2020) · The Brown University Psychopharmacology Update · doi:10.1002/pu.30582

Real-world longitudinal treatment trajectories following opioid use disorder diagnosis among commercially insured beneficiaries in the United States

Rizk, J. G., Qato, D. M., Saini, J., Pathan, U., DiPaula, B. A., Ehret, M. J., Johnson, A. M., & Li, Y. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209858 · Cited by 1

Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey

Lee, S., Sun, L. L., & Vakkalanka, J. P. (2024) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2024.05.015 · Cited by 4